Cite

HARVARD Citation

    Al Draiweesh, S. et al. (2020). Safety of Combination Biologic and Antirejection Therapy Post–Liver Transplantation in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases. 26 (6), pp. 949-959. [Online]. 
  
Back to record